Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v3.5.0.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net earnings $ 152 $ 152
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities    
Depreciation and amortization 111 53
Stock compensation expense 83 33
Deferred income taxes (13) (13)
Gain on contingent consideration (1) (10)
Changes in assets and liabilities    
Premium and related receivables (1,121) (341)
Other current assets (26) (28)
Medical claims liabilities 188 366
Unearned revenue (50) (102)
Accounts payable and accrued expenses (8) 166
Other long term liabilities 463 144
Other operating activities, net (3) (25)
Net cash (used in) provided by operating activities (225) 395
Cash flows from investing activities:    
Capital expenditures (94) (58)
Purchases of investments (956) (513)
Sales and maturities of investments 593 276
Investments in acquisitions, net of cash acquired (862) (11)
Other investing activities, net 0 7
Net cash used in investing activities (1,319) (299)
Cash flows from financing activities:    
Proceeds from borrowings 5,711 750
Payment of long term debt (3,124) (479)
Common stock repurchases (27) (7)
Purchase of noncontrolling interest (14) 0
Debt issue costs (59) (4)
Other financing activities, net 7 1
Net cash provided by financing activities 2,494 261
Net increase in cash and cash equivalents 950 357
Cash and cash equivalents, beginning of period 1,760 1,610
Cash and cash equivalents, end of period 2,710 1,967
Supplemental disclosures of cash flow information:    
Interest paid 36 27
Income taxes paid 222 145
Equity issued in connection with acquisitions $ 3,105 $ 13